Highly active ozonides selected against drug resistant malaria

Lis Lobo, Bruno de Sousa, Lília I L Cabral, Maria L S Cristiano, Fátima Nogueira

Research output: Contribution to journalArticle

1 Citation (Scopus)
1 Downloads (Pure)

Abstract

Ever increasing multi-drug resistance by Plasmodium falciparum is creating new challenges in malaria chemotherapy. In the absence of licensed vaccines, treatment and prevention of malaria is heavily dependent on drugs. Potency, range of activity, safety, low cost and ease of administration are crucial issues in the design and formulation of antimalarials. We have tested three synthetic ozonides NAC89, LC50 and LCD67 in vitro and in vivo against multidrug resistant Plasmodium. In vitro, LC50 was at least 10 times more efficient inhibiting P. falciparum multidrug resistant Dd2 strain than chloroquine and mefloquine and as efficient as artemisinin (ART), artesunate and dihydroartemisinin. All three ozonides showed high efficacy in clearing parasitaemia in mice, caused by multi-drug resistant Plasmodium chabaudi strains, by subcutaneous administration, demonstrating high efficacy in vivo against ART and artesunate resistant parasites.

Original languageEnglish
Pages (from-to)450-453
Number of pages4
JournalMemorias do Instituto Oswaldo Cruz
Volume111
Issue number7
DOIs
Publication statusPublished - 1 Jul 2016

    Fingerprint

Keywords

  • Drug resistance
  • Malaria
  • Ozonides

Cite this